Bacterial Infections  >>  Shanchol (oral cholera vaccine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shanchol (oral cholera vaccine) / Sanofi
NCT01042951: To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh

Completed
2
330
RoW
ShanChol Cholera Vaccine, ShanCholCholera Vaccine, Placebo
International Centre for Diarrhoeal Disease Research, Bangladesh, International Vaccine Institute, Government of Bangladesh
Healthy
08/10
11/10
NCT02742558: Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine

Completed
2
2052
RoW
Cholvax, Shanchol
International Centre for Diarrhoeal Disease Research, Bangladesh, International Vaccine Institute
Cholera
06/17
06/17
NCT02823899: Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine

Completed
1/2
840
RoW
HL-OCV, Shanchol
International Centre for Diarrhoeal Disease Research, Bangladesh, MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.
Cholera
11/17
11/17

Download Options